Relapse of erysipelas following treatment with prednisolone or placebo in addition to antibiotics: a 1-year follow-up

Clicks: 391
ID: 118957
1998
Free PDF
Article Quality & Performance Metrics
Overall Quality
Not rated
Combines reader engagement with the AI quality analysis. This article has not been analysed, so there is no overall score — reader engagement is measured and shown alongside.
AI Quality Assessment
Not analyzed
Readership in this journal
Steady

Ranked #6 of 11 articles by views in scandinavian journal of infectious diseases

Most read Least read

Bar heights use a square-root scale.

Mint this article as an NFT
Not yet minted

Create a permanent, verifiable on-chain record of this article on the Scimatic Network. The NFT is held in your Journament account, and you can withdraw it to your own wallet at any time.

5 SUSD one-off · no wallet required
Sign in to mint
Abstract
Of 112 patients with erysipelas, who were randomized to treatment with 8 d of either prednisolone or placebo in addition to antibiotics, 103 were followed-up for 12 months after they had been cured. The results of the period from 3 weeks up to 1 y after the day of cure are presented. 52 patients cam …
Reference Key
pi1998scandinavianrelapse Use this key to autocite in the manuscript while using SciMatic Manuscript Manager or Thesis Manager
Authors Bergkvist PI;Sjöbeck K;;
Journal scandinavian journal of infectious diseases
Year 1998
DOI
DOI not found
URL
http://www.ncbi.nlm.nih.gov/pubmed/9730318
Keywords
National Center for Biotechnology Information NCBI NLM MEDLINE sweden humans pubmed abstract nih national institutes of health national library of medicine Recurrence Clinical Trial Randomized Controlled Trial follow-up studies time factors drug therapy combination anti-inflammatory agents / therapeutic use* anti-bacterial agents / therapeutic use* erysipelas / drug therapy* pmid:9730318 doi:10.1080/003655498750003708 p i bergkvist k sjöbeck prednisolone / therapeutic use*

Citations

No citations found. To add a citation, contact the admin at info@scimatic.org

Comments

No comments yet. Be the first to comment on this article.